HIGHLIGHTS
- What: Despite its strengths of a relatively long-term follow-up and a large sample size, this study has several limitations.
- Who: Yuki Honda from the Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, have published the research work: Differences between pathologic and non-pathologic high myopia in 4-year outcomes of anti-VEGF therapy for macular neovascularization, in the Journal: Scientific Reports Scientific Reports
- Future: Research regarding this difference is required.
SUMMARY
Since pathologic myopia was defined as being equal to or more severe . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.